2.A Protocol of Korean JOint RegistrY for ALZheimer’s Treatment and Diagnostics (JOY-ALZ)
Geon Ha KIM ; Jung-Min PYUN ; Danbee KANG ; Sung Hoon KANG ; Seong-Ho KOH ; Jae Seung KIM ; So Young MOON ; Won-Jin MOON ; Young Ho PARK ; YongSoo SHIM ; Dong Won YANG ; Young Chul YOUN ; Young Hee JUNG ; Hanna CHO ; Hojin CHOI ; Jae-Sung LIM ; Kee Hyung PARK ; Seong Hye CHOI
Dementia and Neurocognitive Disorders 2026;25(1):25-41
Background:
and Purpose: To assess the long-term effectiveness, safety, and economic viability of recently approved Alzheimer’s disease (AD) therapies, as well as to evaluate the real-world application of novel diagnostics among AD patients with diverse comorbidities, comprehensive real-world data (RWD) analysis is essential. The Korean JOint RegistrY for ALZheimer’s Treatment and Diagnostics (JOY-ALZ) endeavors to create a registry of RWD derived from clinical practice on new diagnostic methods and therapeutic agents for AD introduced in Korea since 2021.
Methods:
Participants must fulfill all the following: 1) be at least 19 years old; 2) be actively receiving, scheduled to initiate, or undergoing evaluation for any AD disease-modifying treatment; 3) have completed amyloid positron emission tomography or cerebrospinal fluid AD immunoassay (a positive result is not essential for participation); 4) have a clinical classification of cognitively unimpaired, mild cognitive impairment, or probable AD dementia. Data generated during routine care is segmented into a minimum dataset, extended dataset, and research-only dataset requiring extra consent. Assessments encompass clinical, cognitive, functional, neurobehavioral, neuroimaging, and biomarker evaluations, in addition to systematic monitoring of new AD treatments and their safety.Data are collected and monitored at baseline, at semiannual intervals during the initial 2 years, and then annually up to 2034. To date, 46 medical centers will participate in JOY-ALZ.
Conclusions
JOY-ALZ is expected to promote understanding of the long-term clinical outcomes, safety, and cost-effectiveness of recently introduced diagnostics and treatments for AD, thereby supporting the progress of precision medicine in AD care and diagnosis.
4.Correcting unfolded helix in a 22-year-old male patient: a case report
Archives of Aesthetic Plastic Surgery 2025;31(1):17-20
An unfolded helix is an auricular deformity that has garnered relatively little research focus. This study introduces a surgical technique designed to correct flat helix deformities. A 22-year-old male with bilateral unfolded helixes and prominent ears underwent this procedure under local anesthesia. The surgery employed a posterior auricular approach, with incisions extending from the upper pole of the ear to the concha. Along the helical rim, four radiating incisions were made, followed by oblique cuts in the cartilage and the creation of triangular flaps through advancement. The free edges of the cartilage were then overlapped and sutured together. Post-surgery, the patient experienced a successful recovery, evidenced by the curling of the helix and the absence of complications. This surgical technique is not only effective for correcting unfolded helixes but can also be efficiently performed under local anesthesia.
5.Correcting unfolded helix in a 22-year-old male patient: a case report
Archives of Aesthetic Plastic Surgery 2025;31(1):17-20
An unfolded helix is an auricular deformity that has garnered relatively little research focus. This study introduces a surgical technique designed to correct flat helix deformities. A 22-year-old male with bilateral unfolded helixes and prominent ears underwent this procedure under local anesthesia. The surgery employed a posterior auricular approach, with incisions extending from the upper pole of the ear to the concha. Along the helical rim, four radiating incisions were made, followed by oblique cuts in the cartilage and the creation of triangular flaps through advancement. The free edges of the cartilage were then overlapped and sutured together. Post-surgery, the patient experienced a successful recovery, evidenced by the curling of the helix and the absence of complications. This surgical technique is not only effective for correcting unfolded helixes but can also be efficiently performed under local anesthesia.
6.Correcting unfolded helix in a 22-year-old male patient: a case report
Archives of Aesthetic Plastic Surgery 2025;31(1):17-20
An unfolded helix is an auricular deformity that has garnered relatively little research focus. This study introduces a surgical technique designed to correct flat helix deformities. A 22-year-old male with bilateral unfolded helixes and prominent ears underwent this procedure under local anesthesia. The surgery employed a posterior auricular approach, with incisions extending from the upper pole of the ear to the concha. Along the helical rim, four radiating incisions were made, followed by oblique cuts in the cartilage and the creation of triangular flaps through advancement. The free edges of the cartilage were then overlapped and sutured together. Post-surgery, the patient experienced a successful recovery, evidenced by the curling of the helix and the absence of complications. This surgical technique is not only effective for correcting unfolded helixes but can also be efficiently performed under local anesthesia.
7.Vertebral Artery Dissection with Acute Ischemic Stroke after COVID-19 Vaccination: Three Case Reports
Hong Keun YOO ; Ji Hyun KIM ; Young Joo LEE ; Kyu Yong LEE ; Seong Ho KOH ; Seong Ho PARK ; Hojin CHOI ; Hyuk Sung KWON
Journal of Neurosonology and Neuroimaging 2025;17(2):37-39
SARS-CoV-2 is a global pandemic with high mortality and prevalence. Although the disease severity has weakened, it remains a significant global health burden as an endemic disease. Several reports have explored the relationship between intracranial artery dissection and SARS-CoV-2 infection; however, an association with SARS-CoV-2 vaccination has not been established. Here, we describe three cases of vertebral arterial dissection with acute ischemic stroke after SARS-CoV-2 vaccination. This report aimed to raise the clinical awareness of this potential adverse effect, which may facilitate earlier diagnosis and intervention.
8.Clinical consequence of hypophosphatemia during antiviral therapy for chronic hepatitis B
Mee Yeon PARK ; Hojin JEON ; Kyungho PARK ; Junseok JEON ; Minsu PARK ; Sang Ah CHI ; Kyunga KIM ; Dong Hyun SINN ; Jung Eun LEE ; Geum-Youn GWAK ; Wooseong HUH ; Yoon-Goo KIM ; Hye Ryoun JANG
Kidney Research and Clinical Practice 2025;44(1):123-131
Antiviral therapy is an essential treatment for chronic hepatitis B (CHB) infection. Although hypophosphatemia is an important adverse effect of antiviral agents, its clinical significance remains unclear. We investigated the incidence and clinical consequences of hypophosphatemia in a large cohort of CHB patients. Methods: This retrospective cohort study included CHB patients who started antiviral therapy between 2005 and 2015 and continued it for at least 1 year. Patients with decompensated liver cirrhosis, diabetes mellitus, hypertension, concomitant diuretic administration, and end-stage renal disease were excluded. The primary outcome was a change in renal function. Secondary outcomes included the incidence of infection and changes in serum potassium, uric acid, and total carbon dioxide (tCO2). Results: Among the 4,335 patients, hypophosphatemia developed in 75 (1.7%). During the median 2-year follow-up period, patients with hypophosphatemia showed a lower estimated glomerular filtration rate than those in the control group. The incidence of infection and changes in serum potassium, uric acid, and tCO2 were similar between groups. Conclusion: Hypophosphatemia was associated with a renal function decline in patients with CHB receiving antiviral therapy.
9.Reinforcing treatment and evaluation workflow of stereotactic ablative body radiotherapy for refractory ventricular tachycardia
Hojin KIM ; Sangjoon PARK ; Jihun KIM ; Jin Sung KIM ; Dong Wook KIM ; Nalee KIM ; Jae-Sun UHM ; Daehoon KIM ; Hui-Nam PAK ; Chae-Seon HONG ; Hong In YOON
Radiation Oncology Journal 2024;42(4):319-329
Purpose:
Cardiac radioablation is a novel, non-invasive treatment for ventricular tachycardia (VT), involving a single fractional stereotactic ablative body radiotherapy (SABR) session with a prescribed dose of 25 Gy. This complex procedure requires a detailed workflow and stringent dose constraints compared to conventional radiation therapy. This study aims to establish a consistent institutional workflow for single-fraction cardiac VT-SABR, emphasizing robust plan evaluation and quality assurance.
Materials and Methods:
The study developed a consistent institutional workflow for VT-SABR, including computed tomography (CT) simulation, target volume definition, treatment planning, robust plan evaluation, quality assurance, and image-guided strategy. The workflow was implemented for two patients with cardiac arrhythmia. Accurate target volume definition using planning CT images and electronic anatomical mapping was critical. A four-dimensional (4D) cone-beam CT (CBCT) and breath-hold electrocardiographic gated CT images reliably detected target motion.
Results:
The resulting plans exhibited a conformity index greater than 0.7 and a gradient index around G4.0. Dose constraints for the planning target volume (PTV) aimed for 95% or higher PTV dose coverage, with a maximum dose of 200% or lower. However, one case did not meet the PTV dose coverage due to the proximity of the PTV to gastrointestinal organs. Plans adhered to dose constraints for organs at risk near the heart, but meeting constraints for specific cardiac sub-structures was challenging and dependent on PTV location.
Conclusion
The plans demonstrated robustness against respiratory motion and patient positional uncertainty through a robust evaluation function. The 4D and intra-fractional CBCT were effective in verifying target motion and setup stability.
10.Evaluation of Aortic Diseases Using Four-Dimensional Flow Magnetic Resonance Imaging
Hyun Jung KOO ; Hojin HA ; Gyu-Han LEE ; Jong En LEE ; Sang-hyub PARK ; Kyoung-jin PARK ; Joon-Won KANG ; Dong Hyun YANG
Vascular Specialist International 2024;40(4):41-
The complex hemodynamic environment within the aortic lumen plays a crucial role in the progression of aortic diseases such as aneurysms and dissections. Traditional imaging modalities often fail to provide comprehensive flow dynamics that are essential for precise risk assessment and timely intervention. The advent of time-resolved, three-dimensional (3D) phase-contrast magnetic resonance imaging (4D flow MRI) has revolutionized the evaluation of aortic diseases by allowing a detailed visualizations of flow patterns and quantification of hemodynamic parameters. This review explores the utility of 4D flow MRI in the assessment of thoracic aortic diseases, highlighting the key hemodynamic parameters, including flow velocity, wall shear stress, oscillatory shear index, relative residence time, vortex, turbulent kinetic energy, flow displacement, pulse wave velocity, aortic distensibility, energy loss, and stasis. We elucidate the significant findings of studies utilizing 4D flow MRI in the context of aortic aneurysms and dissections, highlighting its role in enhancing our understanding of disease mechanisms and improving clinical outcomes. This review underscores the potential of 4D flow MRI to refine risk stratification and guide therapeutic decisions, ultimately contributing to better management of aortic diseases.

Result Analysis
Print
Save
E-mail